The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.

(HealthDay News) — Poor cardiovascular-kidney-metabolic (CKM) health is associated with an increased risk for psoriasis, especially for those with high genetic risk, according to a study published ...

An investigational factor XI inhibitor shows early promise for treating atrial fibrillation in patients with a degree of kidney impairment.

Multiparametric MRI was a game changer for prostate cancer diagnosis. Now trial findings suggest a simpler imaging protocol may be as effective.

However, BCC rates similar by College of American Pathologists and Clinical and Laboratory Standards Institute criteria.

Insomnia linked to faster decline in global cognition scores and increased risk for cognitive impairment in older adults.

The committee found strong evidence that glucagon-like peptide-1 (GLP-1) receptor agonists benefit people with type 2 diabetes, particularly those with heart or kidney disease, by improving glucose ...

Beyond GLP-1 RA prescriptions, chronic kidney disease (CKD) patients require comprehensive care from doctors, dietitians, & ...

Study findings support intensive blood pressure control in patients with hypertension without chronic kidney disease at baseline.

Tumors with higher stromal content may have a TME in an immune-overstimulated state, which could be a factor in their worse prognosis, the researchers suggested. Based on its associations with PD-L1 ...

As changes to Medicare Part D prescription drug coverage have taken effect with implementation of the IRA, concurrent changes in plan design have increased cost-sharing burdens for patients, data ...